Hank Plain is a Partner at Lightstone Ventures where he invests in biotech, medtech, and broader life sciences sectors including oncology, immunology, neurology/CNS, ophthalmology, cardiovascular, precision medicine, and targeted therapeutics. He invests across seed through late-stage venture rounds (Series A–E), and in geographies including the United States and Ireland. He serves on the boards of Access Closure, Acclarent, and Ardian, Inc., and has invested in companies like SetPoint Medical, Nuvaira, ALX Oncology, Nimbus Therapeutics, and Relievant Medsystems. Before Lightstone Ventures, he was a Partner at Morgenthaler Ventures, Vice-Chairman at The Foundry, CEO of Perclose, and held management roles at Eli Lilly and Company. Hank graduated from the University of Missouri–Columbia and lives in Menlo Park, California.
Hank Plain, Partner @ Lightstone. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Hank Plain from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Hank
Map your path to Hank instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Hank
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.